|
|---|
|
Hunt A,
Handorf E,
Blau M,
Chertock Y,
Fang C,
Hall MJ,
Jain R. Psychological distress in patients with metastatic cancer enrolling on phase I clinical trials.
J Cancer Surviv. 2021 Mar 13
:1-5. PMC ID:PMC7955695. |
|
Jain R,
Shaikh T,
Yee JL,
Au C,
Denlinger CS,
Handorf E,
Meyer JE,
Dotan E. Impact of Clinical Markers of Nutritional Status and Feeding Jejunostomy Use on Outcomes in Esophageal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
Nutrients. 2020 Oct 17;12(10)
. PMC ID:PMC7602938. |
|
Provenzale D,
Ness RM,
Llor X,
Weiss JM,
Abbadessa B,
Cooper G,
Early DS,
Friedman M,
Giardiello FM,
Glaser K,
Gurudu S,
Halverson AL,
Issaka R,
Jain R,
Kanth P,
Kidambi T,
Lazenby AJ,
Maguire L,
Markowitz AJ,
May FP,
Mayer RJ,
Mehta S,
Patel S,
Peter S,
PStanich P,
Terdiman J,
Keller J,
Dwyer MA,
Ogba N. NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020.
J Natl Compr Canc Netw. 2020 Oct 1;18(10)
:1312-1320. |
|
McGillivray E,
Farma J,
Savage M,
Hall MJ,
Luo B,
Jain R. Pathologic Complete Response in Patient With ATM Mutation After Neoadjuvant FOLFOXIRI Plus Panitumumab Therapy for Locally Advanced Colon Cancer: A Case Report.
Clin Colorectal Cancer. 2020 Sep 18
. |
|
Wainberg ZA,
Hochster HS,
Kim EJ,
George B,
Kaylan A,
Chiorean EG,
Waterhouse DM,
Guiterrez M,
Parikh AR,
Jain R,
Carrizosa DR,
Soliman H,
Lila T,
Reiss DJ,
Pierce DW,
Bhore R,
Banerjee S,
Lyons L,
Louis CU,
Ong TJ,
O'Dwyer PJ. Open-Label, Phase 1 Study of Nivolumab Combined With nab-Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer.
Clin Cancer Res. 2020 Sep 15;26(18)
:4814-4822. |
|
Jain R,
Coss C,
Whooley P,
Phelps M,
Owen DH. The Role of Malnutrition and Muscle Wasting in Advanced Lung Cancer.
Curr Oncol Rep. 2020 May 15;22(6)
:54. |
|
Wong JK,
Handorf E,
Lee D,
Jain R,
Zhang E,
Cooper HS,
Farma JM,
Dotan E,
Meyer JE. Toxicity and outcomes in older versus younger patients treated with trimodality therapy for locally advanced rectal cancer.
J Geriatr Oncol. 2020 May 4;11(8)
:1331-1334. PMC ID:PMC7606716. |
|
Jain R,
Vijayvergia N,
Devarajan K,
Lewis B,
Denlinger CS,
Cohen SJ,
Dotan E. Chemotherapy use and survival in older adults with metastatic pancreatic cancer in the combination therapy era.
J Geriatr Oncol. 2020 May;11(4)
:640-646. PMC ID:PMC7567610. |
|
Jain R,
Yee JL,
Shaikh T,
Au C,
Handorf E,
Meyer JE,
Dotan E. Treatment-related toxicity and outcomes in older versus younger patients with esophageal cancer treated with neoadjuvant chemoradiation.
J Geriatr Oncol. 2020 May;11(4)
:668-674. |
|
Jain R,
Handorf E,
Khare V,
Blau M,
Chertock Y,
Hall MJ. Impact of Baseline Nutrition and Exercise Status on Toxicity and Outcomes in Phase I and II Oncology Clinical Trial Participants.
Oncologist. 2020 Feb;25(2)
:161-169. PMC ID:PMC7011642. |
|
Jain R,
Yee JL,
Shaikh T,
Au C,
Handorf E,
Meyer JE,
Dotan E. Treatment-related toxicity and outcomes in older versus younger patients with esophageal cancer treated with neoadjuvant chemoradiation.
J Geriatr Oncol. 2019 Jun 27
. |
|
Martinez Chanza N,
Xie W,
Asim Bilen M,
Dzimitrowicz H,
Burkart J,
Geynisman DM,
Balakrishnan A,
Bowman IA,
Jain R,
Stadler W,
Zakharia Y,
Narayan V,
Beuselinck B,
McKay RR,
Tripathi A,
Pachynski R,
Hahn AW,
Hsu J,
Shah SA,
Lam ET,
Rose TL,
Mega AE,
Vogelzang N,
Harrison MR,
Mortazavi A,
Plimack ER,
Vaishampayan U,
Hammers H,
George S,
Haas N,
Agarwal N,
Pal SK,
Srinivas S,
Carneiro BA,
Heng DYC,
Bosse D,
Choueiri TK,
Harshman LC. Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.
Lancet Oncol. 2019 Apr;20(4)
:581-590. PMC ID:PMC6849381. |
|
Jain R,
Denlinger CS. Incorporating Weight Management into Clinical Care for Cancer Survivors: Challenges, Opportunities, and Future Directions.
Obesity (Silver Spring). 2017 Nov;25 Suppl 2
:S27-s29. PMC ID:PMC5744874. |
|
Barta SK,
Jain R,
Mazumder A,
Carter J,
Almanzar L,
Browne R,
Shahnaz S,
Elkind R,
Kaminetzky D,
Battini R,
Derman O,
Kornblum N,
Verma A,
Braunschweig I. Pharmacokinetics-directed Intravenous Busulfan Combined With High-dose Melphalan and Bortezomib as a Conditioning Regimen for Patients With Multiple Myeloma.
Clin Lymphoma Myeloma Leuk. 2017 Oct;17(10)
:650-657. |
|
Jain R,
Dotan E. Nutrition and Aging: a Practicing Oncologist's Perspective.
Curr Oncol Rep. 2017 Sep 07;19(11)
:71. |
|
Jain R,
Savage MJ,
Forman AD,
Mukherji R,
Hall MJ. The Relevance of Hereditary Cancer Risks to Precision Oncology: What Should Providers Consider When Conducting Tumor Genomic Profiling?.
J Natl Compr Canc Netw. 2016 Jun;14(6)
:795-806. |
|
Knollman H,
Godwin JL,
Jain R,
Wong YN,
Plimack ER,
Geynisman DM. Muscle-invasive urothelial bladder cancer: An update on systemic therapy.
Ther Adv Urol. 2015 Dec;7(6)
:312-330. PMC ID:PMC4647143. |
|
Faculty
Publications
